Edgewise Therapeutics, Inc. EWTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Edgewise Therapeutics, Inc. (EWTX) reported operating lease right-of-use assets in other assets of $1.33M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 12.7% year-over-year, from $1.53M to $1.33M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 1.7% compound annual growth rate (CAGR), from $1.32M to $1.39M.